Clover Health Investments Corp [CLOV] stock is trading at $2.97, up 4.95%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling.
From an analyst’s perspective:
Clover Health Investments Corp [NASDAQ: CLOV] stock has seen the most recent analyst activity on December 17, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $6. Previously, UBS started tracking the stock with Neutral rating on October 07, 2024, and set its price target to $4. On February 02, 2022, upgrade upgraded it’s rating to Market Perform and revised its price target to $3 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $6 on February 02, 2022. SVB Leerink initiated its recommendation with a Mkt Perform and recommended $3 as its price target on January 19, 2022. In a note dated January 07, 2022, Credit Suisse downgraded an Underperform rating on this stock and revised its target price from $9 to $3.50.
Clover Health Investments Corp [CLOV] stock has fluctuated between $1.01 and $4.87 over the past year. Currently, Wall Street analysts expect the stock to reach $3.43 within the next 12 months. Clover Health Investments Corp [NASDAQ: CLOV] shares were valued at $2.97 at the most recent close of the market. An investor can expect a potential return of 15.49% based on the average CLOV price forecast.
Analyzing the CLOV fundamentals
Clover Health Investments Corp [NASDAQ:CLOV] reported sales of 1.49B for the trailing twelve months, which represents a growth of 33.45%. Gross Profit Margin for this corporation currently stands at 0.26% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.07 and Total Capital is -0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.84 points at the first support level, and at 2.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.05, and for the 2nd resistance point, it is at 3.14.
Ratios To Look Out For
For context, Clover Health Investments Corp’s Current Ratio is 1.54. Considering the valuation of this stock, the price to sales ratio is 1.02, the price to book ratio is 4.25.
Transactions by insiders
Recent insider trading involved Reynoso Jamie L., CEO, Medicare Advantage, that happened on Jun 17 ’25 when 20450.0 shares were sold. Officer, JAMIE REYNOSO completed a deal on Jun 17 ’25 to buy 20450.0 shares. Meanwhile, Director Edwards Carladenise Armbrister sold 0.2 million shares on Mar 07 ’25.
